TEVA

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change -0.11
Percentage change -1.12	%

Index	-	P/E	-	EPS (ttm)	-1.98	Insider Own	0.01%	Shs Outstand	1.12B	Perf Week	1.68%
Market Cap	10.88B	Forward P/E	4.02	EPS next Y	2.41	Insider Trans	-44.49%	Shs Float	1.12B	Perf Month	10.84%
Income	-2209.00M	PEG	-	EPS next Q	0.75	Inst Own	50.34%	Short Float / Ratio	1.27% / 1.61	Perf Quarter	-1.32%
Sales	15.31B	P/S	0.71	EPS this Y	-8.28%	Inst Trans	9.11%	Short Interest	14.18M	Perf Half Y	34.30%
Book/sh	6.18	P/B	1.57	EPS next Y	4.47%	ROA	-5.12%	Target Price	10.88	Perf Year	10.72%
Cash/sh	2.01	P/C	4.84	EPS next 5Y	1.60%	ROE	-28.17%	52W Range	7.09 - 11.44	Perf YTD	6.47%
Dividend	-	P/FCF	5.58	EPS past 5Y	33.47%	ROI	-8.58%	52W High	-15.16%	Beta	1.19
Dividend %	-	Quick Ratio	0.65	Sales past 5Y	-7.61%	Gross Margin	45.95%	52W Low	37.05%	ATR	0.30
Employees	36826	Current Ratio	1.00	Sales Q/Q	7.50%	Oper. Margin	17.40%	RSI (14)	60.82	Volatility	2.97% 3.20%
Optionable	Yes	Debt/Eq	2.93	EPS Q/Q	41.00%	Profit Margin	-14.43%	Rel Volume	0.73	Prev Close	9.82
Shortable	Yes	LT Debt/Eq	2.72	Earnings	Nov 08 BMO	Payout	-	Avg Volume	8.80M	Price	9.71
Recom	2.54	SMA20	5.61%	SMA50	6.30%	SMA200	9.56%	Volume	6,412,000	Change	-1.12%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-27-23	Upgrade	UBS	Neutral → Buy	$11 → $13
Jul-06-23	Upgrade	UBS	Sell → Neutral	$7 → $8
May-25-23	Initiated	Morgan Stanley	Equal-Weight	$10
May-18-23	Upgrade	Evercore ISI	In-line → Outperform
Jan-19-23	Downgrade	Jefferies	Buy → Hold	$10 → $12
Nov-14-22	Downgrade	JP Morgan	Neutral → Underweight	$11 → $10
Nov-04-22	Downgrade	UBS	Neutral → Sell
Oct-21-22	Resumed	Jefferies	Buy	$10
Aug-05-22	Upgrade	BofA Securities	Neutral → Buy	$10 → $13
Jun-14-22	Resumed	UBS	Neutral	$10
May-17-22	Upgrade	BofA Securities	Underperform → Neutral	$9
May-04-22	Downgrade	Piper Sandler	Neutral → Underweight	$11 → $7
Apr-05-22	Upgrade	Barclays	Equal Weight → Overweight	$11 → $13
Mar-25-22	Upgrade	Bernstein	Mkt Perform → Outperform	$11
Jan-27-22	Downgrade	Argus	Buy → Hold
Oct-28-21	Downgrade	Raymond James	Outperform → Mkt Perform
May-04-21	Downgrade	UBS	Buy → Neutral	$15 → $11
Apr-07-21	Resumed	RBC Capital Mkts	Sector Perform	$11
Nov-25-20	Initiated	Oppenheimer	Perform
Aug-06-20	Upgrade	Barclays	Underweight → Equal Weight	$10 → $13

Show Previous Ratings

Nov-30-23 08:30AM	Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment (Business Wire)
Nov-27-23 10:14AM	Teva Pharmaceutical upgraded to 'Buy' at UBS (Yahoo Finance Video)
09:56AM	Roku upgraded, Lucid Group downgraded: Wall Street's top analyst calls (The Fly)
09:37AM	Teva Pharmaceutical: Long-Term Cash Cow (GuruFocus.com)
08:15AM	Midday movers: Affirm, Amazon, and More (Investing.com)
01:50AM	Loading…
01:50AM	Roku raised to Buy, YPF extends gains following upgrade: 4 big analyst picks (Investing.com)
Nov-24-23 08:16PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
Nov-20-23 04:30PM	Teva to Present at the 6th Annual Evercore ISI HealthCONx Conference (Business Wire)
Nov-17-23 08:30AM	Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S. (Business Wire)
Nov-15-23 07:03PM	50 Most Populated Countries in 2030 (Insider Monkey)
Nov-13-23 08:10AM	Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program (GlobeNewswire)
08:00AM	Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program (Business Wire)
Nov-12-23 12:02AM	Decoding Teva Pharmaceutical Industries Ltd (TEVA): A Strategic SWOT Insight (GuruFocus.com)
Nov-09-23 01:21PM	Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 04:31PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
04:01PM	Loading…
04:01PM	Teva Pharma Makes A Bullish Move After Quarterly Beat, Business Separation Plans (Investor's Business Daily)
03:05PM	Teva Pharmaceutical Industries Ltd (TEVA) Reports Q3 2023 Earnings and Raises Revenue Outlook (GuruFocus.com)
02:15PM	Teva Pharmaceutical Industries (TEVA) Q3 2023 Earnings Call Transcript (Motley Fool)
01:22PM	Israels Teva Lifts Outlook With War Not Curbing Drug Production (Bloomberg)
12:05PM	Teva Pharmaceutical Nears Breakout On Quarterly Beat, Business Separation (Investor's Business Daily)
09:30AM	Teva Pharmaceutical Industries Ltd. (TEVA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
09:01AM	Teva Closes In On A Buy Point On Third-Quarter Beat, Business Separation (Investor's Business Daily)
08:04AM	UPDATE 3-Teva says Israel-Hamas war not hurting production, eyes growth in 2024 (Reuters)
07:40AM	Teva says Israel-Hamas war not hurting production, eyes growth in 2024 (Reuters)
07:37AM	Teva Pharm Q3 profit rises, sees higher 2023 revenue (Reuters)
07:27AM	Teva Pharma Boosts FY23 Revenue Outlook - Update (RTT News)
07:00AM	Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance (Business Wire)
Nov-07-23 04:30PM	Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business (Business Wire)
Nov-02-23 11:23AM	Exelixis (EXEL) Q3 Earnings and Sales Miss, Annual View Updated (Zacks)
08:00AM	Teva to Present New Data Supporting Safety, Efficacy and Real-World Effectiveness of AUSTEDO® (deutetrabenazine) Tablets at the 2023 HSG Annual Meeting (Business Wire)
07:31PM	Loading…
Nov-01-23 07:31PM	UZEDY (risperidone) Extended-Release Injectable Suspension Significantly Prolongs Time to Schizophrenia Relapse in RISE Study Results Published in The Lancet Psychiatry (Business Wire)
Oct-30-23 04:35PM	13 Most Undervalued Pharma Stocks To Buy According To Analysts (Insider Monkey) +5.30%
Oct-25-23 09:00AM	Teva to Provide Second Round of Funding to Clinics in California, Florida and New Jersey as Part of $2 Million Commitment Through Community Routes: Access to Mental Health Care Program (Business Wire)
Oct-18-23 04:56AM	Israeli drugmaker Teva loses appeal against EU fine -EU court ruling (Reuters)
Oct-17-23 01:30AM	Teva Phase IV UNITE Study Shows AJOVY® (fremanezumab) Reduced Migraine Attacks and Depression Symptoms in Migraine Sufferers with Major Depressive Disorder (Business Wire)
Oct-10-23 12:26PM	UPDATE 1-Drugmaker Teva does not see big impact on business from Israel-Hamas war (Reuters)
10:52AM	Teva Pharm does not see big impact on business from Israel-Hamas war (Reuters)
Oct-06-23 05:11PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:30PM	Teva to Host Conference Call to Discuss Third Quarter 2023 Financial Results at 8 a.m. ET on November 8, 2023 (Business Wire)
Oct-04-23 07:45PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
04:08PM	Teva Leans Into Sanofi's 'Pipeline-In-A-Product' Expertise In $1.5 Billion Deal (Investor's Business Daily)
10:47AM	Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble. (Investor's Business Daily)
10:37AM	Sanofi (SNY) Signs Deal to Co-Develop Teva's IBD Candidate (Zacks)
01:07AM	Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment (Business Wire)
Sep-28-23 04:05PM	Teva Announces Changes to Executive Management Team (Business Wire)
Sep-26-23 04:33PM	US judge overturns Eli Lilly's $176.5 million loss in Teva patent case (Reuters)
Sep-20-23 07:34PM	Unveiling Teva Pharmaceutical Industries (TEVA)'s Value: Is It Really Priced Right? A ... (GuruFocus.com)
Sep-13-23 05:21AM	3 No-Brainer Stocks to Buy With $20 Right Now (Motley Fool)
Sep-06-23 04:30PM	Teva to Present at the 21st Annual Morgan Stanley Global Healthcare Conference (Business Wire)
08:00AM	Teva to Present Data for AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, AUSTEDO® (deutetrabenazine) Tablets and UZEDY (risperidone) Extended-Release Injectable Suspension at Psych Congress 2023 (Business Wire)
Sep-01-23 12:04AM	Q2 2023 Alvotech SA Earnings Call (Thomson Reuters StreetEvents)
Aug-31-23 11:02AM	Alkermes (ALKS) Grants Teva License to Market Generic Drug (Zacks)
Aug-23-23 03:49AM	TEVA to Pay $225 Million to Settle Price-Fixing Charges (Revised) (Zacks)
Aug-22-23 01:22PM	Teva Pharma: generics titan attempts to put the stopper in legal problems (Financial Times)
09:19AM	TEVA to Pay $250 Million to Settle Price-Fixing Charges (Zacks)
Aug-21-23 07:27PM	Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges (The Wall Street Journal)
06:48PM	Teva to pay $225M to settle cholesterol drug price-fixing charges (AP Finance)
04:32PM	UPDATE 2-Teva to pay $225 mln, divest cholesterol drug to settle price-fixing charges (Reuters)
04:12PM	Teva to pay $225 million, divest cholesterol drug to settle price-fixing charges (Reuters)
04:09PM	Teva Pharmaceuticals to pay $225 mln to settle price-fixing charges (Reuters)
04:00PM	Teva Settles Price Fixing Charges With U.S. DOJ (Business Wire)
Aug-15-23 05:54AM	Q2 2023 Societal CDMO Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-14-23 07:01AM	Zacks Industry Outlook Highlights Amphastar Pharmaceuticals, Dr. Reddy's Laboratories and Teva Pharmaceutical (Zacks)
Aug-11-23 10:33AM	3 Generic Drug Stocks to Watch Amid Improving Market Prospects (Zacks)
Aug-03-23 12:45PM	Teva agrees to pay $126 million to US hospitals over opioids (Reuters)
12:41PM	Teva agrees to pay $126 mln to US hospitals over opioids (Reuters)
11:22AM	TEVA Q2 Earnings & Sales Top as Austedo Outperforms, Stock Up (Zacks)
Aug-02-23 11:26PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research) +11.58%
05:20PM	Teva stock pops on Q2 results, CEO sees 'significant' potential for trio of branded drugs (Yahoo Finance Video)
04:01PM	Teva Retakes Its 200-Day Line After Second-Quarter Beat And Raise (Investor's Business Daily)
01:40PM	UPDATE 1-Teva CEO says not too late to launch Humira biosimilar in 2024 (Reuters)
11:49AM	Teva Pharm CEO: Not too late to launch Humira biosimilar in 2024 (Reuters)
11:00AM	Teva Pharmaceutical Industries (TEVA) Q2 2023 Earnings Call Transcript (Motley Fool)
10:30AM	Here's What Key Metrics Tell Us About Teva Pharmaceutical Industries Ltd. (TEVA) Q2 Earnings (Zacks)
09:00AM	Teva Takes A Run At Its 200-Day Line After Second-Quarter Beat And Raise (Investor's Business Daily)
07:40AM	UPDATE 1-Teva Pharmaceutical Q2 profit tops estimates, Huntington's drug sales jump (Reuters)
07:21AM	Huntington's drug sales help Teva Pharma beat profit estimates (Reuters)
07:18AM	Teva Pharmaceutical Q2 profit tops estimates, Huntington's drug sales jump (Reuters)
07:00AM	Teva Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-31-23 07:35AM	Analyst Report: Teva Phar Inds Lt (Argus Research)
07:20AM	Market Digest: TEVA, BFH, BYD, CMS, CNC, EQR, FHI, ITGR, GD, INTC, IP, KLAC, MAS, MSFT, PCAR, RTX, WM (Argus Research)
Jul-27-23 08:00AM	Teva Announces Appointment of Dr. Angus Grant to Executive Vice President, Business Development (Business Wire)
Jul-24-23 03:06PM	Exelixis deal sets generic version of cancer drug for release in 2031 (American City Business Journals)
04:00AM	Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership (GlobeNewswire)
Jul-06-23 09:54AM	Teva considers sale of its active ingredients unit: Bloomberg (Yahoo Finance Video)
03:32AM	Teva Weighs Sale of $2 Billion Active Ingredients Unit (Bloomberg)
Jul-05-23 05:38PM	Teva's Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit (Benzinga)
04:30PM	Teva to Host Conference Call to Discuss Second Quarter 2023 Financial Results at 8 a.m. ET on August 2, 2023 (Business Wire)
Jun-30-23 12:30PM	Tevas 3rd interim analysis of PEARL real-world study on AJOVY® (fremanezumab) reveals sustained long-term effectiveness in reducing frequency, duration and severity of attacks in patients with chronic and episodic migraine (Business Wire)
Jun-28-23 02:54PM	Patients Cant Get Some Lifesaving Drugs. Whats Causing the Shortages. (Barrons.com)
Jun-24-23 03:19PM	11 Best Medical Stocks Under $10 (Insider Monkey)
Jun-17-23 06:10AM	3 Bargain Stocks to Buy on the Dip (Motley Fool)
Jun-15-23 08:00AM	Teva to Present Data at the 2023 American Headache Society Annual Scientific Meeting Demonstrating AJOVY® (fremanezumab-vfrm) Injection Significantly Reduced Migraine and Depression Symptoms in Patients (Business Wire)
Jun-12-23 04:00PM	Teva Reaches Agreement With Kentucky to Settle the States Price Fixing Claims (Business Wire)
07:00AM	Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara® (Business Wire)
Jun-09-23 02:08PM	Pharmaceutical Giants Set $19 Billion Opioid Settlement as States Debate How to Spend It (The Wall Street Journal)
Jun-08-23 12:15PM	Is AbbVie or Amgen the Better Bargain Buy Right Now? (Motley Fool)
08:30AM	Teva Concludes Nationwide Opioids Settlement Agreement (Business Wire)
Jun-07-23 05:15PM	Teva to pay Nevada $193 million over role in opioid epidemic (Reuters)
Jun-06-23 08:00AM	Phil and Teva Pharmaceuticals Launch New Program to Improve Access to the Digihaler® Family of Inhalers to Support Asthma Management (Business Wire)

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kalif Eliyahu Sharon	EVP, Chief Financial Officer	Aug 07	Sale	9.73	35,125	341,889	99,162	Aug 09 04:02 PM
Weiss Amir	Chief Accounting Officer	Aug 04	Sale	9.92	1,981	19,658	42,442	Aug 07 04:15 PM
Hughes Eric A	See "Remarks"	Aug 01	Sale	8.30	52,742	437,690	0	Aug 03 07:09 AM
Dethlefs Sven	EVP, North America Commercial	Mar 07	Sale	9.43	58,066	547,440	165,381	Mar 08 04:03 PM
Daniell Richard	Exec. VP, European Commercial	Mar 07	Sale	9.43	54,007	509,173	69,770	Mar 08 04:02 PM
Stark David Matthew	Exec. VP Chief Legal Officer	Mar 07	Sale	9.43	49,475	466,445	2,974	Mar 08 04:05 PM
Drape Eric	Executive VP Global Operations	Mar 07	Sale	9.43	4,699	44,302	173,262	Mar 08 04:04 PM
Dethlefs Sven	EVP, North America Commercial	Mar 06	Sale	9.93	19,355	192,213	223,447	Mar 08 04:03 PM
Daniell Richard	Exec. VP, European Commercial	Mar 06	Sale	9.93	18,002	178,776	123,777	Mar 08 04:02 PM
Stark David Matthew	Exec. VP Chief Legal Officer	Mar 06	Sale	9.93	16,491	163,770	52,449	Mar 08 04:05 PM
Drape Eric	Executive VP Global Operations	Mar 06	Sale	9.93	1,566	15,552	177,961	Mar 08 04:04 PM
Stark David Matthew	Exec. VP Chief Legal Officer	Feb 28	Sale	9.89	63,383	626,642	2,974	Mar 02 07:38 AM
Dethlefs Sven	EVP, North America Commercial	Feb 28	Sale	9.89	59,655	589,785	165,381	Mar 02 07:33 AM
Daniell Richard	Exec. VP, European Commercial	Feb 28	Sale	9.89	44,252	437,502	43,182	Mar 02 07:33 AM
Drape Eric	Executive VP Global Operations	Feb 28	Sale	9.89	33,685	333,030	87,789	Mar 02 07:34 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Teva- Pharmaceutical Industries Ltd. ADR

Upgrade your FINVIZ experience